AstraZeneca Pharma India Limited (BOM:506820)
India · Delayed Price · Currency is INR 9,535.45
+73.60 (0.78%)
At close: Oct 31, 2025
AstraZeneca Pharma India Market Cap
AstraZeneca Pharma India has a market cap or net worth of 245.43 billion as of November 3, 2025. Its market cap has increased by 27.97% in one year.
Market Cap
245.43B
Enterprise Value
240.43B
Revenue
18.55B
Ranking
n/a
PE Ratio
133.88
Stock Price
9,535.45
Market Cap Chart
Since February 27, 2002, AstraZeneca Pharma India's market cap has increased from 1.45B to 245.43B, an increase of 16,826.38%. That is a compound annual growth rate of 24.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 238.39B | 30.45% |
| Dec 31, 2024 | 182.75B | 32.43% |
| Dec 29, 2023 | 138.00B | 67.65% |
| Dec 30, 2022 | 82.31B | 6.20% |
| Dec 31, 2021 | 77.51B | -32.91% |
| Dec 31, 2020 | 115.54B | 76.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reliance Industries | 20.11T |
| HDFC Bank | 15.17T |
| Bharti Airtel | 12.32T |
| Tata Consultancy Services | 11.06T |
| ICICI Bank | 9.61T |
| State Bank of India | 8.65T |
| Bajaj Finance | 6.47T |
| Infosys | 6.14T |